Still a place for conventional histopathological analysis in the era of molecular medicine: predicting prognosis of resectable ductal pancreatic adenocarcinoma

dc.contributor.authorFernández Aceñero, María Jesús
dc.contributor.authorMartinez Useros, J
dc.contributor.authorDíez Valladares, Luis Ignacio
dc.contributor.authorGarcía Botella, Alejandra María
dc.contributor.authorOrtega Medina, Luis
dc.contributor.authorPérez Aguirre, María Elia
dc.contributor.authorDe la-Serna Esteban, Sofía Cristina
dc.contributor.authorLatorre, E
dc.contributor.authorNeelsen, L
dc.date.accessioned2026-01-13T13:50:46Z
dc.date.available2026-01-13T13:50:46Z
dc.date.issued2019-06-24
dc.description.abstractIntroductionOur aim is to find features that define prognosis in surgically resected ductal pancreatic adenocarcinoma readily accessible in everyday practice.Materials and methodsLongitudinal retrospective case series of pancreatic adenocarcinoma operated with a curative intent in a large tertiary hospital in Madrid between 2009 and 2015.Results162 were enrolled. 40.8% survived less than 1year. Multivariate Cox's regression model revealed that gender, presence of symptoms, T and N stage independently influenced progression-free survival, while overall survival was determined by gender, smoking, presence of symptoms and N stage. Logistic regression analysis revealed that only symptoms at diagnosis could predict death, while gender, symptoms, histopathological type, vessel invasion, T stage and necrosis could independently predict recurrence.DiscussionOur series show that patients with symptomatic disease at the time of diagnosis and females showed a shorter progression-free and overall survival. We herein propose a regression model to predict outcome.
dc.description.departmentDepto. de Cirugía
dc.description.facultyFac. de Medicina
dc.description.refereedTRUE
dc.description.statuspub
dc.identifier.issn1699-048X
dc.identifier.officialurlhttps://doi.org/10.1007/s12094-018-02008-4
dc.identifier.relatedurlhttps://link.springer.com/article/10.1007/s12094-018-02008-4
dc.identifier.urihttps://hdl.handle.net/20.500.14352/130078
dc.issue.number7
dc.journal.titleCLINICAL & TRANSLATIONAL ONCOLOGY
dc.language.isoeng
dc.page.final959
dc.page.initial954
dc.publisherSPRINGER
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.accessRightsrestricted access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.cdu611.018
dc.subject.keywordAdenocarcinoma
dc.subject.keywordPancreas
dc.subject.keywordPrognosis
dc.subject.keywordSurgical therapy
dc.subject.ucmCiencias Biomédicas
dc.subject.unesco32 Ciencias Médicas
dc.titleStill a place for conventional histopathological analysis in the era of molecular medicine: predicting prognosis of resectable ductal pancreatic adenocarcinoma
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number21
dspace.entity.typePublication
relation.isAuthorOfPublication17fa7c60-58c8-45c6-a7b3-e74d45a588cb
relation.isAuthorOfPublication1dd06eb1-8704-4b70-831b-6d5672cdb8d8
relation.isAuthorOfPublication78d41194-9f02-4647-a36e-73c145350d4a
relation.isAuthorOfPublicationf3708ff4-8e32-49d4-b04b-b68b0c55fd2c
relation.isAuthorOfPublication678bc7a5-fbcd-4ec1-a047-d73132c37942
relation.isAuthorOfPublication5662c135-3aac-4ff9-a69f-091ce49be52d
relation.isAuthorOfPublication.latestForDiscovery17fa7c60-58c8-45c6-a7b3-e74d45a588cb

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Still a place for conventional histopathological analysis in the era of molecular medicine- predicting prognosis of resectable ductal pancreatic adenocarcinoma.pdf
Size:
472.58 KB
Format:
Adobe Portable Document Format

Collections